Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01432626 · ClinicalTrials.gov registry record · NA
Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG
A NA study of Stress Induced Cardiomyopathy, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01432626 is a NA study of Stress Induced Cardiomyopathy that has completed, run by University of Pittsburgh. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01432626, a NA study of Stress Induced Cardiomyopathy, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Objective: The objective of this pilot study is to characterize the cardiac uptake patterns of I-123 mIBG in stress-induced (Takotsubo's) cardiomyopathy. Hypothesis: Perturbations in sympathetic innervation are the underlying pathogenesis of stress induced cardiomyopathy and will result in abnormalities in I-123 mIBG cardiac imaging. Thus, planar and SPECT I-123 MIBG imaging will provide insight into the pathogenesis of stress-induced cardiomyopathy, and may lead to the development of more specific diagnostic criteria. Study design: This proposal is for a prospective pilot study to characterize perturbations in cardiac sympathetic innervation in patients with stress induced cardiomyopathy by performing planar and SPECT I-123 MIBG imaging during the acute presentation and after recovery of LV function.
Conditions Studied
Interventions
- DRUG I-123 radiolabeled metaiodobenzylguanidine cardiac imaging
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01432626
The ClinicalTrials.gov registry entry for NCT01432626 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stress Induced Cardiomyopathy appearing as the primary indexed condition, and to 1 intervention - of which I-123 radiolabeled metaiodobenzylguanidine cardiac imaging is the first listed.
NCT01432626 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01432626 about?
NCT01432626 is a clinical study titled "Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG". Objective: The objective of this pilot study is to characterize the cardiac uptake patterns of I-123 mIBG in stress-induced (Takotsubo's) cardiomyopathy. Hypothesis: Perturbations in sympathetic innervation are the underlying pathogenesis of stress induced cardiomyopathy and will result in abnormal...
What is the current status of trial NCT01432626?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2011-09. Estimated completion is 2015-06.
What conditions does trial NCT01432626 study?
This clinical trial studies the following conditions: Stress Induced Cardiomyopathy.
What interventions are being tested in trial NCT01432626?
The interventions under investigation include: I-123 radiolabeled metaiodobenzylguanidine cardiac imaging (DRUG).
Who is sponsoring clinical trial NCT01432626?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01432626 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.